Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "DBC1 protein, human"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma
Youngran Kang, Woon Yong Jung, Hyunjoo Lee, Eunjung Lee, Aeree Kim, Baek-hui Kim
Korean J Pathol. 2012;46(6):523-531.   Published online December 26, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.6.523
  • 8,081 View
  • 47 Download
  • 29 Crossref
AbstractAbstract PDF
Background

Sirtuin 1 (SIRT1) and deleted in breast cancer 1 (DBC1) are known as tumor suppressor or promoter genes. This may be due to their diverse functions and interaction with other proteins. Gastric adenocarcinoma is one of the most common malignancies, but little is known about its carcinogenesis. Therefore, we investigated the association of immunohistochemical expression of SIRT1, DBC1, p53, and β-catenin and their variable clinicopathological characteristics.

Methods

We obtained samples from 452 patients who underwent gastrectomy. Tissue microarray blocks were constructed and immonohistochemical staining was performed.

Results

Expression of DBC1 and SIRT1 was associated with lower histologic grade, intestinal type of Lauren classification, and lower pT (p<0.001) and pN stage (DBC1, p=0.002; SIRT1, p<0.001). Association between absence of lymphatic invasion, and SIRT1 (p=0.001) and DBC1 (p=0.004) was observed. Cytoplasmic β-catenin expression was associated with lower histologic grade, pT, pN, tumor-node-metastasis (TNM) stage, DBC1 (p<0.001), and SIRT1 (p=0.001). Expression of SIRT1 and DBC1 was not associated with p53 (p=0.063 and p=0.060). DBC1 was an independent good prognostic factor in multivariate analysis (p=0.012).

Conclusions

SIRC1 and DBC1 can be considered to be good prognostic factors in gastric adenocarcinoma.

Citations

Citations to this article as recorded by  
  • Mechanistic insights into the dual role of CCAR2/DBC1 in cancer
    Hwa Jin Kim, Sue Jin Moon, Jeong Hoon Kim
    Experimental & Molecular Medicine.2023; 55(8): 1691.     CrossRef
  • Sirtuins (SIRTs) As a Novel Target in Gastric Cancer
    Agata Poniewierska-Baran, Paulina Warias, Katarzyna Zgutka
    International Journal of Molecular Sciences.2022; 23(23): 15119.     CrossRef
  • Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
    Amandine Badie, Christian Gaiddon, Georg Mellitzer
    Cancers.2022; 14(21): 5472.     CrossRef
  • Advances on the role of the deleted in breast cancer (DBC1) in cancer and autoimmune diseases
    Qiannan Fang, Joseph A Bellanti, Song Guo Zheng
    Journal of Leukocyte Biology.2021; 109(2): 449.     CrossRef
  • miR-1301-3p Promotes Cell Proliferation and Facilitates Cell Cycle Progression via Targeting SIRT1 in Gastric Cancer
    Dakui Luo, Hao Fan, Xiang Ma, Chao Yang, Yu He, Yugang Ge, Mingkun Jiang, Zekuan Xu, Li Yang
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis
    Gavin S. Johnson, Praveen Rajendran, Roderick H. Dashwood
    Cancer Science.2020; 111(10): 3416.     CrossRef
  • Role of histone acetylation in gastric cancer: implications of dietetic compounds and clinical perspectives
    Danielle Q Calcagno, Fernanda Wisnieski, Elizangela R da Silva Mota, Stefanie B Maia de Sousa, Jéssica M Costa da Silva, Mariana F Leal, Carolina O Gigek, Leonardo C Santos, Lucas T Rasmussen, Paulo P Assumpção, Rommel R Burbano, Marília AC Smith
    Epigenomics.2019; 11(3): 349.     CrossRef
  • Survival and Clinicopathological Significance of SIRT1 Expression in Cancers: A Meta-Analysis
    Min Sun, Mengyu Du, Wenhua Zhang, Sisi Xiong, Xingrui Gong, Peijie Lei, Jin Zha, Hongrui Zhu, Heng Li, Dong Huang, Xinsheng Gu
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Cell cycle and apoptosis regulator 2 at the interface between DNA damage response and cell physiology
    Martina Magni, Giacomo Buscemi, Laura Zannini
    Mutation Research/Reviews in Mutation Research.2018; 776: 1.     CrossRef
  • NANOGP8 expression regulates gastric cancer cell progression by transactivating DBC1 in gastric cancer MKN‑45 cells
    Li Li, Ru Feng, Sujuan Fei, Jiang Cao, Qinqin Zhu, Guozhong Ji, Jianwei Zhou
    Oncology Letters.2018;[Epub]     CrossRef
  • Overexpression of DBC1, correlated with poor prognosis, is a potential therapeutic target for hepatocellular carcinoma
    Changcan Li, Jianhua Liao, Shaohan Wu, Junwei Fan, Zhihai Peng, Zhaowen Wang
    Biochemical and Biophysical Research Communications.2017; 494(3-4): 511.     CrossRef
  • Association of sirtuins with clinicopathological parameters and overall survival in gastric cancer
    Xiaobing Shen, Pengfei Li, Yuchao Xu, Xiaowei Chen, Haixiang Sun, Ying Zhao, Mengqi Liu, Wenwen Zhang
    Oncotarget.2017; 8(43): 74359.     CrossRef
  • Co-ordinated overexpression of SIRT1 and STAT3 is associated with poor survival outcome in gastric cancer patients
    Shu Zhang, Shuling Huang, Chao Deng, Yu Cao, Jun Yang, Guangxia Chen, Bin Zhang, Chaoqin Duan, Jiong Shi, Bo Kong, Helmut Friess, Nanyi Zhao, Chen Huang, Xiaoli Huang, Lei Wang, Xiaoping Zou
    Oncotarget.2017; 8(12): 18848.     CrossRef
  • The prognostic role of Sirt1 expression in solid malignancies: a meta-analysis
    Changwen Wang, Wen Yang, Fang Dong, Yawen Guo, Jie Tan, Shengnan Ruan, Tao Huang
    Oncotarget.2017; 8(39): 66343.     CrossRef
  • SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer
    Min-Sun Jin, Chang Lim Hyun, In Ae Park, Ji Young Kim, Yul Ri Chung, Seock-Ah Im, Kyung-Hun Lee, Hyeong-Gon Moon, Han Suk Ryu
    Tumor Biology.2016; 37(4): 4743.     CrossRef
  • Prognostic and clinical value of Sirt1 expression in gastric cancer: A systematic meta-analysis
    Bin Jiang, Jin-huang Chen, Wen-zheng Yuan, Jin-tong Ji, Zheng-yi Liu, Liang Wu, Qiang Tang, Xiao-gang Shu
    Journal of Huazhong University of Science and Technology [Medical Sciences].2016; 36(2): 278.     CrossRef
  • Significance of silent mating type information regulation 2 homolog 1 and claudin 4 expression in gastric carcinoma and precursor lesions
    Nashwa M. Emara, Ranih Z. Amer, Khaled M. Elsadek Attia, Heba M. Rashad, Adel Z. Elseady, Abd El-Latif M. Elbalshy
    Egyptian Journal of Pathology.2016; 36(2): 158.     CrossRef
  • Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype
    Yul Ri Chung, Hyojin Kim, Soo Young Park, In Ae Park, Ja June Jang, Ji-Young Choe, Yoon Yang Jung, Seock-Ah Im, Hyeong-Gon Moon, Kyung-Hun Lee, Koung Jin Suh, Tae-Yong Kim, Dong-Young Noh, Wonshik Han, Han Suk Ryu
    Human Pathology.2015; 46(7): 1027.     CrossRef
  • SIRT1 is a regulator of autophagy: Implications in gastric cancer progression and treatment
    Guanglin Qiu, Xuqi Li, Xiangming Che, Chao Wei, Shicai He, Jing Lu, Zongliang Jia, Ke Pang, Lin Fan
    FEBS Letters.2015; 589(16): 2034.     CrossRef
  • DBC1 Functions as a Tumor Suppressor by Regulating p53 Stability
    Bo Qin, Katherine Minter-Dykhouse, Jia Yu, Jun Zhang, Tongzheng Liu, Haoxing Zhang, SeungBaek Lee, JungJin Kim, Liewei Wang, Zhenkun Lou
    Cell Reports.2015; 10(8): 1324.     CrossRef
  • DBC1 promotes anoikis resistance of gastric cancer cells by regulating NF-κB activity
    YONGWEI HUAN, DEPING WU, DAYONG ZHOU, BO SUN, GUOXIN LI
    Oncology Reports.2015; 34(2): 843.     CrossRef
  • Resveratrol relieves ischemia‑induced oxidative stress in the hippocampus by activating SIRT1
    Zhuangzhi Meng, Jianguo Li, Honglin Zhao, Haiying Liu, Guowei Zhang, Lingzhan Wang, He Hu, Di Li, Mingjing Liu, Fulong Bi, Xiaoping Wang, Geng Tian, Qiang Liu, Batu Buren
    Experimental and Therapeutic Medicine.2015;[Epub]     CrossRef
  • CCAR2 deficiency augments genotoxic stress-induced apoptosis in the presence of melatonin in non-small cell lung cancer cells
    Wootae Kim, Joo-Won Jeong, Ja-Eun Kim
    Tumor Biology.2014; 35(11): 10919.     CrossRef
  • Radioprotective and Antioxidant Effect of Resveratrol in Hippocampus by Activating Sirt1
    Jianguo Li, Li Feng, Yonghua Xing, Yan Wang, Liqing Du, Chang Xu, Jia Cao, Qin Wang, Saijun Fan, Qiang Liu, Feiyue Fan
    International Journal of Molecular Sciences.2014; 15(4): 5928.     CrossRef
  • SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer
    Akira Noguchi, Keiji Kikuchi, Huachuan Zheng, Hiroyuki Takahashi, Yohei Miyagi, Ichiro Aoki, Yasuo Takano
    Cancer Medicine.2014; 3(6): 1553.     CrossRef
  • Sirtuins and Cancer: New Insights and Cell Signaling
    Marcos Vinícius Macedo de Oliveira, João Marcus Oliveira Andrade, Alanna Fernandes Paraíso, Sérgio Henrique Sousa Santos
    Cancer Investigation.2013; 31(10): 645.     CrossRef
  • Deleted in breast cancer-1 (DBC-1) in the interface between metabolism, aging and cancer
    Eduardo Nunes Chini, Claudia C. S. Chini, Veronica Nin, Carlos Escande
    Bioscience Reports.2013;[Epub]     CrossRef
  • SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer
    Wonkyung Jung, Kwang Dae Hong, Woon Yong Jung, Eunjung Lee, Bong Kyung Shin, Han Kyeom Kim, Aeree Kim, Baek-hui Kim
    Korean Journal of Pathology.2013; 47(4): 332.     CrossRef
  • Clinicopathological significance of SIRT1 and p300/CBP expression in gastroesophageal junction (GEJ) cancer and the correlation with E-cadherin and MLH1
    Li-Hua Zhang, Qin Huang, Xiang-Shan Fan, Hong-Yan Wu, Jun Yang, An-Ning Feng
    Pathology - Research and Practice.2013; 209(10): 611.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine